Literature DB >> 12138206

Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.

Zhi-Kai Zhang1, Kelvin P Davies, Jeffrey Allen, Liang Zhu, Richard G Pestell, David Zagzag, Ganjam V Kalpana.   

Abstract

INI1/hSNF5 is a component of the ATP-dependent chromatin remodeling hSWI/SNF complex and a tumor suppressor gene of aggressive pediatric atypical teratoid and malignant rhabdoid tumors (AT/RT). To understand the molecular mechanisms underlying its tumor suppressor function, we studied the effect of reintroduction of INI1/hSNF5 into AT/RT-derived cell lines such as MON that carry biallelic deletions of the INI1/hSNF5 locus. We demonstrate that expression of INI1/hSNF5 causes G(0)-G(1) arrest and flat cell formation in these cells. In addition, INI1/hSNF5 repressed transcription of cyclin D1 gene in MON, in a histone deacetylase (HDAC)-dependent manner. Chromatin immunoprecipitation studies revealed that INI1/hSNF5 was directly recruited to the cyclin D1 promoter and that its binding correlated with recruitment of HDAC1 and deacetylation of histones at the promoter. Analysis of INI1/hSNF5 truncations indicated that cyclin D1 repression and flat cell formation are tightly correlated. Coexpression of cyclin D1 from a heterologous promoter in MON was sufficient to eliminate the INI1-mediated flat cell formation and cell cycle arrest. Furthermore, cyclin D1 was overexpressed in AT/RT tumors. Our data suggest that one of the mechanisms by which INI1/hSNF5 exerts its tumor suppressor function is by mediating the cell cycle arrest due to the direct recruitment of HDAC activity to the cyclin D1 promoter thereby causing its repression and G(0)-G(1) arrest. Repression of cyclin D1 gene expression may serve as a useful strategy to treat AT/RT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12138206      PMCID: PMC133966          DOI: 10.1128/MCB.22.16.5975-5988.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Retinoblastoma protein switches the E2F site from positive to negative element.

Authors:  S J Weintraub; C A Prater; D C Dean
Journal:  Nature       Date:  1992-07-16       Impact factor: 49.962

Review 2.  Adenoviral E1A: everlasting tool, versatile applications, continuous contributions and new hypotheses.

Authors:  Nianli Sang; Jaime Caro; Antonio Giordano
Journal:  Front Biosci       Date:  2002-02-01

3.  Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1.

Authors:  E Yung; M Sorin; A Pal; E Craig; A Morozov; O Delattre; J Kappes; D Ott; G V Kalpana
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

4.  Repression of cyclin D1: a novel function of MYC.

Authors:  A Philipp; A Schneider; I Väsrik; K Finke; Y Xiong; D Beach; K Alitalo; M Eilers
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

Review 5.  The SNF/SWI family of global transcriptional activators.

Authors:  M Carlson; B C Laurent
Journal:  Curr Opin Cell Biol       Date:  1994-06       Impact factor: 8.382

6.  Function of a human cyclin gene as an oncogene.

Authors:  P W Hinds; S F Dowdy; E N Eaton; A Arnold; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

7.  Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.

Authors:  J Lukas; M Pagano; Z Staskova; G Draetta; J Bartek
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

8.  BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription.

Authors:  P A Khavari; C L Peterson; J W Tamkun; D B Mendel; G R Crabtree
Journal:  Nature       Date:  1993-11-11       Impact factor: 49.962

9.  c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II.

Authors:  L H Li; C Nerlov; G Prendergast; D MacGregor; E B Ziff
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

10.  A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor.

Authors:  C Muchardt; M Yaniv
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

View more
  93 in total

1.  Growth inhibition by the mammalian SWI-SNF subunit Brm is regulated by acetylation.

Authors:  Brigitte Bourachot; Moshe Yaniv; Christian Muchardt
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

2.  Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition.

Authors:  Pablo Gómez-del Arco; Kazushige Maki; Katia Georgopoulos
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

3.  Crippling SWI-SNF makes tumors GLI-ful.

Authors:  Jeremy F Reiter
Journal:  Nat Med       Date:  2010-12       Impact factor: 53.440

Review 4.  Biology and Treatment of Rhabdoid Tumor.

Authors:  James I Geller; Jacquelyn J Roth; Jaclyn A Biegel
Journal:  Crit Rev Oncog       Date:  2015

5.  The chromatin-remodeling protein Osa interacts with CyclinE in Drosophila eye imaginal discs.

Authors:  Jawaid Baig; Francoise Chanut; Thomas B Kornberg; Ansgar Klebes
Journal:  Genetics       Date:  2009-12-14       Impact factor: 4.562

6.  Epigenetic dysregulation in cancer.

Authors:  Andrew G Muntean; Jay L Hess
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

7.  Acetylation: a lysine modification with neuroprotective effects in ischemic retinal degeneration.

Authors:  Oday Alsarraf; Jie Fan; Mohammad Dahrouj; C James Chou; Donald R Menick; Craig E Crosson
Journal:  Exp Eye Res       Date:  2014-07-23       Impact factor: 3.467

8.  Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes.

Authors:  Diane K Birks; Andrew M Donson; Purvi R Patel; Alexandra Sufit; Elizabeth M Algar; Christopher Dunham; B K Kleinschmidt-DeMasters; Michael H Handler; Rajeev Vibhakar; Nicholas K Foreman
Journal:  Pediatr Blood Cancer       Date:  2013-02-04       Impact factor: 3.167

9.  17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.

Authors:  Yaming Qiao; Zhi-Kai Zhang; Li-Qun Cai; Chen Tan; Julianne L Imperato-McGinley; Yuan-Shan Zhu
Journal:  Prostate       Date:  2007-12-01       Impact factor: 4.104

10.  mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad.

Authors:  Sharmistha Pal; Romy Yun; Antara Datta; Lynne Lacomis; Hediye Erdjument-Bromage; Jitendra Kumar; Paul Tempst; Saïd Sif
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.